Diminished expression of apical sodium-dependent bile acid transporter in gallstone disease is independent of ileal inflammation

Digestion

Volumn 78, Issue 1, 2008, Pages 52-59

  Holzer, Arthur ^a   Harsch, Simone ^a   Renner, Olga ^a   Strohmeyer, André ^a   Schimmel, Silke ^a   Wehkamp, Jan ^a   Fritz, Peter ^b   Stange, Eduard F ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

Author keywords

Apical sodium dependent bile acid transporter; c fos; c jun; Inflammation; Interleukin 1 ; Interleukin 8; Tumor necrosis factor

Indexed keywords

APICAL SODIUM DEPENDENT BILE ACID TRANSPORTER; INTERLEUKIN 1BETA; INTERLEUKIN 8; ORGANIC ANION TRANSPORTER; PROTEIN C FOS; PROTEIN C JUN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CHOLELITHIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEUM DISEASE; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; GALLSTONES; HUMANS; ILEITIS; ILEUM; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-8; MIDDLE AGED; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; SYMPORTERS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52849088394     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000159379     Document Type: Article

References (33)

1. Lammert F, Sauerbruch T: Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol Hepatol 2005;2:423-433.
2. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU: Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005;41:1138-1143.
3. Berr F, Pratschke E, Fischer S, Paumgartner G: Disorders of bile acid metabolism in cholesterol gallstone disease. J Clin Invest 1992;90:859-868.
4. Shoda J, He BF, Tanaka N, Matsuzaki Y, Osuga T, Yamamori S, Miyazaki H, Sjövall J: Increase of deoxycholate in supersaturated bile of patients with cholesterol gallstone disease and its correlation with de novo syntheses of cholesterol and bile acids in liver, gallbladder emptying, and small intestinal transit. Hepatology 1995;21:1291-1302.
5. Berr F, Kullak-Ublick GA, Paumgartner G, Münzing W, Hylemon PB: 7α-Dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology 1996;111:1611-1620.
6. Thomas LA, Veysey MJ, Murphy GM, Russell-Jones D, French GL, Wass JA, Dowling RH: Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly. Gut 2005;54: 630-635.
7. Brand B, Lerche L, Stange EF: Symptomatic or asymptomatic gallstone disease: is the gallbladder motility the clue? Hepatogastroenterology 2002;49:1208-1212.
8. Dawson PA, Haywood J, Craddock AL, Wilson M, Tietjen M, Kluckman K, Maeda N, Parks JS: Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice. J Biol Chem 2003;278:33920-33927.
9. Bergheim I, Harsch S, Mueller O, Schimmel S, Fritz P, Stange EF: Apical sodium bile acid transporter and ileal lipid binding protein in gallstone carriers. J Lipid Res 2006;47:42-50.
10. Mamianetti A, Garrido D, Carducci CD, Vescina MC: Fecal bile acid excretion profile in gallstone patients. Medicina (Buenos Aires) 1999;59:269-273.
11. Gälman C, Miquel JF, Pèrez RM, Einarsson C, Stahle L, Marshall G, Nervi F, Rudling M: Bile acid synthesis is increased in Chilean Hispanics with gallstones and in gallstone high-risk Mapuche Indians. Gastroenterology 2004;126:741-748.
12. Stange EF, Scheibner J, Ditschuneit H: Role of primary and secondary bile acids as feed-back inhibitors of bile acid synthesis in the rat in vivo. J Clin Invest 1989;84:173-180.
13. Scheibner J, Fuchs M, Schiemann M, Stange EF: Deoxycholate and cholate modulate the source of cholesterol substrate for bile acid synthesis in the rat. Hepatology 1995;21:529-538.
14. +-dependent bile acid transport activity in rabbit small intestine correlates with the coexpression of an integral 93-kDa and a peripheral 14-kDa bile acid-binding membrane protein along the duodenum-ileum axis. J Biol Chem 1993;268:18035- 18046.
15. Gong YZ, Everett ET, Schwartz DA, Norris JS, Wilson FA: Molecular cloning, tissue distribution and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol. Proc Natl Acad Sci USA 1994;91:4741-4745.
16. Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV, Ballatori N: The heteromeric organic solute transporter α/β, OSTα -OSTβ, is an ileal basolateral bile acid transporter. J Biol Chem 2005;280:6960-6968.
17. Renner O, Harsch H, Strohmeyer A, Schimmel S, Stange EF: Reduced ileal expression of organic solute transporter α and β (OSTα- OSTβ) in normal weight gallstone disease. J Lipid Res 2008 (in press).
18. Jung D, Fantin AC, Scheurer U, Fried M, Kullak-Ublick GA: Human ileal bile acid transporter gene ASBT (SLC10A2) is trans-activated by the glucocorticoid receptor. Gut 2004;53:78-84.
19. Heuman R, Sjodahl R, Tobiasson P, Tagesson C: Postprandial serum bile acids in resected and non-resected patients with Crohn's disease. Scand J Gastroenterol 1982;17:137-140.
20. Stelzner M, Somasundaram S, Khakberdiev T: Systemic effects of acute terminal ileitis on uninflamed gut aggravates bile acid malabsorption. J Surg Res 2001;99:359-364.
21. Lapidus A, Bangstad M, Aström M, Muhrbeck O: The prevalence of gallstone disease in a defined cohort of patients with Crohn's disease. Am J Gastroenterol 1999;94:1261-1266.
22. Brink MA, Slors JF, Keulemans YC, Mok KS, De Waart DR, Carey MC, Groen AK, Tytgat GN: Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology 1999;116:1420-1427.
23. Pereira SP, Bain IM, Kumar D, Dowling RH: Bile composition in inflammatory bowel disease and colectomy, but not colitis, induce lithogenic bile. Aliment Pharmacol Ther 2003;17:923-933.
24. Lapidus A, Åkerlund JE, Einarsson C: Gallbladder bile composition in patients with Crohn's disease. World J Gastroenterol 2006;12:70-74.
25. Chen F, Ma L, Sartor RB, Li F, Xiong H, Sun AQ, Shneider B: Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation. Gastroenterology 2002;123:2005-2016.
26. Lyons MA, Wittenburg H: Susceptibility to cholesterol gallstone formation: evidence that LITH genes also encode immune-related factors. Biochim Biophys Acta 2006;1761:1133-1147.
27. Neimark E, Chen F, Li X, Magid MS, Alasio TM, Frankenberg T, Sinha J, Dawson PA, Shneider BL: c-fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter. Gastroenterology 2006;131:554-567.
28. Stange EF, Travis SPL, Vermeire S, et al: European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006;55:1-15.
29. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
30. Xia X, Roundtree M, Merikhi A, Lu X, Shentu S, LeSage G: Degradation of the apical sodium-dependent bile acid transporter by the ubiquitin-proteasome pathway in cholangiocytes. J Biol Chem 2004;279:44931-44937.
31. Le Vee M, Gripon P, Stieger B, Fardel O: Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin-1β. Drug Metab Dispos 2008;36:217-222.
32. Koj A: Initiation of acute phase response and synthesis of cytokines. Biochim Biophys Acta 1996;1317:84-94.
33. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-16486.